These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22750649)

  • 1. The stem cell signature of CHH/CHG methylation is not present in 271 cancer associated 5'UTR gene regions.
    Pulverer W; Wielscher M; Panzer-Grümayer R; Plessl T; Kriegner A; Vierlinger K; Weinhäusel A
    Biochimie; 2012 Nov; 94(11):2345-52. PubMed ID: 22750649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most methylation-susceptible DNA sequences in human embryonic stem cells undergo a change in conformation or flexibility upon methylation.
    Shimooka Y; Nishikawa J; Ohyama T
    Biochemistry; 2013 Feb; 52(8):1344-53. PubMed ID: 23356538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic values of GHSR DNA methylation pattern in breast cancer.
    Botla SK; Gholami AM; Malekpour M; Moskalev EA; Fallah M; Jandaghi P; Aghajani A; Bondar IS; Omranipour R; Malekpour F; Mohajeri A; Babadi AJ; Sahin Ö; Bubnov VV; Najmabadi H; Hoheisel JD; Riazalhosseini Y
    Breast Cancer Res Treat; 2012 Oct; 135(3):705-13. PubMed ID: 22899222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
    Kim JH; Kang HS; Kim TW; Kim SJ
    Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
    Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
    Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
    Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
    Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.
    Reinert T; Modin C; Castano FM; Lamy P; Wojdacz TK; Hansen LL; Wiuf C; Borre M; Dyrskjøt L; Orntoft TF
    Clin Cancer Res; 2011 Sep; 17(17):5582-92. PubMed ID: 21788354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent down-regulation of HIVEP2 in human breast cancer.
    Fujii H; Gabrielson E; Takagaki T; Ohtsuji M; Ohtsuji N; Hino O
    Breast Cancer Res Treat; 2005 May; 91(2):103-12. PubMed ID: 15868437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array.
    Yu YP; Paranjpe S; Nelson J; Finkelstein S; Ren B; Kokkinakis D; Michalopoulos G; Luo JH
    Carcinogenesis; 2005 Feb; 26(2):471-9. PubMed ID: 15485992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative DNA methylation profiling on a high-density oligonucleotide microarray.
    Fassbender A; Lewin J; König T; Rujan T; Pelet C; Lesche R; Distler J; Schuster M
    Methods Mol Biol; 2010; 576():155-70. PubMed ID: 19882262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
    Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
    Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
    Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
    J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of DNA methylation markers for diagnosing cancer.
    Qureshi SA; Bashir MU; Yaqinuddin A
    Int J Surg; 2010; 8(3):194-8. PubMed ID: 20139036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
    Shen Y; Chow J; Wang Z; Fan G
    Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation testing and marker validation using PCR: diagnostic applications.
    Egger G; Wielscher M; Pulverer W; Kriegner A; Weinhäusel A
    Expert Rev Mol Diagn; 2012 Jan; 12(1):75-92. PubMed ID: 22133121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.